Related Experiment Video
Updated: Jun 4, 2025
08:02
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.5K
Extracellular Vesicles and Their Applications in Tumor Diagnostics and Immunotherapy
Scott Strum1,2, Valentina Evdokimova3, Laszlo Radvanyi4
1Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.
Cells
|December 17, 2024
Summary
Extracellular vesicles (EVs) are nanoparticles crucial for cancer biology and immunotherapy. This review explores their roles in cancer, immunity, and clinical trials, highlighting their potential for future cancer treatment discovery.
Area of Science:
- Oncology
- Immunology
- Nanotechnology
Background:
- Extracellular vesicles (EVs) are cell-derived nanoparticles involved in cancer biology, influencing tumor proliferation and metastasis.
- EVs play a significant role in both innate and adaptive immunity, impacting cancer immune responses.
- Immunotherapy is transforming cancer treatment, necessitating a deeper understanding of EV mechanisms.
Purpose of the Study:
- To review the current applications of EVs in clinical trials for solid tumors and immunotherapy.
- To provide an overview of the roles EVs play in cancer biology and immunology.
- To discuss the implications of EVs in cancer immunotherapy and future research directions.
Main Methods:
- Literature review of existing clinical trials involving EVs in cancer.
- Summary of research on EV functions in oncogenesis and immune modulation.
- Analysis of the potential of EVs in advancing cancer diagnostics and therapeutics.
Main Results:
- EVs are increasingly recognized for their diagnostic and therapeutic potential in cancer.
- Clinical trial applications of EVs, particularly in solid tumors and immunotherapy, remain limited, often focusing on biomarker roles.
- EVs are implicated in various aspects of cancer biology and immune system augmentation.
Conclusions:
- There is a critical need to increase the incorporation of EVs in future clinical trials and correlative studies.
- EVs hold significant promise for synergistic advancements with multi-omics research in cancer therapy.
- Further research into EVs can enhance our understanding of cancer biology and drive therapeutic discovery.
Related Concept Videos
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K